Literature DB >> 24621831

Higher dose dexamethasone increases early postoperative cognitive dysfunction.

Qiwu Fang1, Xiaoyan Qian, Jianxiong An, Hui Wen, Doris K Cope, John P Williams.   

Abstract

OBJECTIVE: To investigate the effects of intravenous administration of dexamethasone on early postoperative cognitive dysfunction (POCD).
METHODS: In this prospective randomized trial, 1000 patients with facial spasm undergoing microvascular decompression (MVD) were randomly assigned to receive normal sodium (Dex-0 group, n=333), dexamethasone 0.1 mg/kg (Dex-1 group, n=333), or dexamethasone 0.2 mg/kg (Dex-2 group, n=334). Exclusion criteria included: a history of neurologic or mental disease, renal failure, active liver disease, cardiac or pulmonary dysfunction, endocrine, metabolic, or peptic ulcer disease, a history of past surgery, <6 years of schooling, inability to complete neuropsychological testing, visual dysfunction, and auditory dysfunction. Patients were also excluded at any point if additional steroid was required. Propofol and sufentanil were administered for anesthetic induction, whereas propofol and remifentanil were given for maintenance of anesthesia. A battery of 9 neuropsychological tests was administered preoperatively and the on day 5 postoperatively. A postoperative deficit was defined as a postoperative decrement to preoperative score of >1SD on any test. Patients who experienced >2 deficits were considered to have experienced early POCD.
RESULTS: Nine hundred and fifty-four patients completed both preoperative and postoperative neuropsychological testing. Within the 3 groups: Dex-0 group, n=319; Dex-1 group, n=320 and Dex-2, n=315. POCD occurred in 71 patients (22.3%) in the Dex-0 group, in 66 patients (20.6%) in the Dex-1 group, and 99 patients (31.4%) in the Dex-2 group. POCD was significant among the 3 groups (P=0.003). Partitions of χ method was applied for multiple comparisons showing that Dex-2 group was significantly different from Dex-1 and Dex-0 groups.
CONCLUSIONS: Administration of higher dose of dexamethasone (0.2 mg/kg) increases the incidence of POCD in the early postoperative period after microvascular decompression under general anesthesia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24621831     DOI: 10.1097/ANA.0000000000000024

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  14 in total

Review 1.  Postoperative Cognitive Dysfunction: Minding the Gaps in Our Knowledge of a Common Postoperative Complication in the Elderly.

Authors:  Miles Berger; Jacob W Nadler; Jeffrey Browndyke; Niccolo Terrando; Vikram Ponnusamy; Harvey Jay Cohen; Heather E Whitson; Joseph P Mathew
Journal:  Anesthesiol Clin       Date:  2015-07-16

Review 2.  Postoperative cognitive disorders: an update.

Authors:  M P Ntalouka; E Arnaoutoglou; P Tzimas
Journal:  Hippokratia       Date:  2018 Oct-Dec       Impact factor: 0.471

3.  Effects of vasodilator and esmolol-induced hemodynamic stability on early post-operative cognitive dysfunction in elderly patients: a randomized trial.

Authors:  Sheng-Hui Sun; Lin Yang; De-Feng Sun; Yue Wu; Jun Han; Ruo-Chuan Liu; Li-Jie Wang
Journal:  Afr Health Sci       Date:  2016-12       Impact factor: 0.927

Review 4.  Perioperative Pain Control in the Ambulatory Setting.

Authors:  Maunak V Rana; Ravi Desai; Lien Tran; D'Andra Davis
Journal:  Curr Pain Headache Rep       Date:  2016-03

5.  Whole transcriptome sequencing reveals dexmedetomidine-improves postoperative cognitive dysfunction in rats via modulating lncRNA.

Authors:  Fumou Deng; Lily Cai; Bin Zhou; Zhidong Zhou; GuoHai Xu
Journal:  3 Biotech       Date:  2020-04-13       Impact factor: 2.406

6.  Effects of Glucocorticoids on Postoperative Neurocognitive Disorders in Adult Patients: A Systematic Review and Meta-Analysis.

Authors:  Xiaoyu Xie; Rui Gao; Hai Chen; Xueying Zhang; Xingwei Cai; Changteng Zhang; Changliang Liu; Tao Zhu; Chan Chen
Journal:  Front Aging Neurosci       Date:  2022-06-30       Impact factor: 5.702

Review 7.  NLRP3 inflammasomes are involved in the progression of postoperative cognitive dysfunction: from mechanism to treatment.

Authors:  Shuai Zhao; Fan Chen; Dunwei Wang; Wei Han; Yuan Zhang; Qiliang Yin
Journal:  Neurosurg Rev       Date:  2020-09-12       Impact factor: 3.042

8.  Pain management in ambulatory surgery-a review.

Authors:  Jan G Jakobsson
Journal:  Pharmaceuticals (Basel)       Date:  2014-07-24

Review 9.  Perioperative Neurocognitive Disorder: State of the Preclinical Science.

Authors:  Roderic G Eckenhoff; Mervyn Maze; Zhongcong Xie; Deborah J Culley; Sarah J Goodlin; Zhiyi Zuo; Huafeng Wei; Robert A Whittington; Niccolò Terrando; Beverley A Orser; Maryellen F Eckenhoff
Journal:  Anesthesiology       Date:  2020-01       Impact factor: 8.986

10.  Parecoxib prevents early postoperative cognitive dysfunction in elderly patients undergoing total knee arthroplasty: A double-blind, randomized clinical consort study.

Authors:  Yang-Zi Zhu; Rui Yao; Zhe Zhang; Hui Xu; Li-Wei Wang
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.